SCHW vs STRO · P/E 19, rev $23.92B vs rev $62.0M
Charles Schwab Corp (SCHW) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SCHW revenue for 2025-12-31 was $23.92B. Net income was $8.85B. Revenue was up 22.0% from 2024-12-31 to 2025-12-31. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SCHW currently screens at market cap $164.37B and trailing P/E 18.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SCHW and STRO stock pages for the full models.
Not investment advice.